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A ccess to safe and reliable contraception is critical for reproductive-aged females and their male part-ners. On average, Canadian females aged 30  years 
or more spend 3  years trying to conceive, pregnant or 
immediately post partum;1 they spend the remainder of 
their reproductive years trying to avoid pregnancy. As a 
public health measure, equitable access to affordable con-
traception supports healthy spacing between planned preg-
nancies, reduces the number of high-risk pregnancies2 and 
decreases avoidable health care expenditures associated with 
unintended pregnancies.3,4 An estimated 30%–40% of preg-
nancies in Canada are unintended1,3 and disproportionately 
affect adolescents and young adults5,6 and other vulnerable 
groups, including recent immigrants, rural residents and 
those of lower socioeconomic status.7 Despite growing evi-
dence of benefits associated with increasing access to con-
traception, both publicly funded provincial and private 
health insurance plans often limit access to the full range of 
contraceptive options available in Canada. There are 
numerous barriers to contraceptive use in Canada, includ-
ing high cost, restricted access to care and limitations in 
health care providers’ knowledge or counselling.8–11
Among contraceptives currently available in Canada, the 
more effective methods1,12 are also the most expensive 
(Table 1) and underused, particularly among vulnerable popu-
lations.2 Although oral contraceptives are the most commonly 
used hormonal method in Canada,13 over 50% of youth 
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Background: Low socioeconomic status is one of many barriers that may limit access to family planning services. We aimed to 
examine the relation between household income and contraceptive methods among female youth in Canada.
Methods: Our study population included sexually active females aged 15–24 who were trying to avoid pregnancy. We used cross-
sectional data from the 2009–2010 and 2013–2014 cycles of the Canadian Community Health Survey to compare household income 
and other sociodemographic covariates for those using oral contraceptives, injectable contraceptives, condoms or a dual method 
(condoms plus oral or injectable contraceptives).
Results: Of female youth at risk for unintended pregnancy, 59.2% reported using oral contraceptives, 29.0% used dual methods, 16.8% 
used condoms only, 2.5% used injectable contraceptives and 13.6% did not use contraception. In multiple regression models, lower 
annual household income (< $80 000) was associated with decreased use of oral contraceptives (relative risk [RR] 0.85, 95% confi-
dence interval [CI] 0.80–0.91) and dual methods (RR 0.81, 95% CI 0.71–0.91), increased use of condoms (RR 1.36, 95% CI 1.11–1.67) 
and injectable contraceptives (RR 1.69, 95% CI 0.98–2.92), and a greater risk of contraceptive nonuse (RR 1.19, 95% CI 0.94–1.50).
Interpretation: We found that lower household income was associated with decreased use of oral contraceptives and increased reli-
ance on injectable contraceptives and condoms only. Young, low-income females may face barriers to accessing the full range of 
contraceptive methods available in Canada. Easier access to affordable contraception may decrease the number of female youth at 
risk for unintended pregnancy due to financial barriers.
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report using condoms only,1 which may be due to ease of 
access (nonprescription, no health care visit required, rela-
tively inexpensive or available free of cost).14 Data on intra-
uterine contraceptives in Canada are not available because 
nationally representative surveys have not included questions 
about this method. In a recent qualitative study, Canadian 
health care providers cited cost as the primary barrier to con-
traception access nationwide.15 In Quebec, where contracep-
tion is subsidized, residents report the lowest proportion of 
unmet contraceptive need compared to other provinces.16 
Low income and immigrant status are also associated with 
nonuse of contraceptives.17,18 Despite evidence of financial 
barriers to contraception access,19 the relation between 
income and choice of contraceptive method among young 
Canadian females is not well understood. The aim of the pres-
ent study was to investigate the association between house-
hold income and contraceptive methods in a nationally repre-
sentative survey sample of sexually active Canadian females 
aged 15–24.
Methods
Data source, design and study population
In this cross-sectional study, we used public use microdata 
files from 2 cycles (2009–2010 and 2013–2014) of the Cana-
dian Community Health Survey (CCHS).20 The CCHS col-
lects information related to use of health care services, health 
status and determinants of health in Canada. The survey sam-
ple is derived by means of a multistage stratified cluster ran-
dom sampling design. Canada-wide response rates were 
72.3% in CCHS 2009–2010 and 66.2% in CCHS 2013–
2014.20,21 Further details of CCHS sampling methods are 
available from Statistics Canada.20,21
Analytic sample
The sample was drawn from CCHS respondents who were 
asked about contraceptives, which included respondents 
from all the provinces and territories in these survey cycles 
aged 15–24. We included those at risk for unintended preg-
nancy: females who were ever sexually active, were not cur-
rently pregnant, had not had a hysterectomy and responded 
“agree” or “strongly agree” to the statement “It is important 
to me to avoid getting pregnant right now.” Inclusion/exclu-
sion criteria and sample sizes are shown in Figure 1. We 
coded “don’t know,” “refusal,” “not applicable” and “not 
stated” responses as missing; the primary analysis used com-
plete cases. Records with missing covariates (6.5%) were 
excluded.
Outcome variables
For contraceptive users, we determined each respondent’s 
method of contraception based on her response to the ques-
tion “What is your usual form of birth control?” Respon-
dents could select 1 or more methods from the following 
6 options: “the pill, injections, condoms, diaphragm, spermi-
cide or other.” Outcome variables were the use of 1) any oral 
contraceptive, 2)  injectable contraceptives (depot medroxy-
progesterone acetate [DMPA]), 3) nonprescription methods 
(condoms only, condoms and spermicide, or spermicide 
only; referred to as condoms-only method [respondents who 
used condoms and spermicide, or spermicide without con-
doms accounted for < 0.2%]) or 4)  dual method (condoms 
plus oral contraceptives or DMPA). As these outcomes were 
not mutually exclusive, we considered each outcome inde-
pendently. Any respondents who used the contraceptive 
patch or ring, intrauterine contraceptives, calendar methods 
or withdrawal were included in the “other” group. Since the 
CCHS questionnaire did not distinguish between different 
contraceptive methods in the “other” group, we could not 
examine these outcomes (including intrauterine contracep-
tive use) in this study. We defined nonusers of contraception 
as those who responded “no” to the question “In the past 
12  months, did you and your partner usually use birth 
control?”
Exposure variable
Our exposure variable was annual household income of 
$80 000 or more (yes/no), derived from the 5-level household 
income variable provided in the CCHS data sets. The cut-
point for high versus low income was based on the estimated 
median family income in Canada for 2-parent families with 
children in 2010 ($78 800).22
Statistical analysis
We examined the prevalence of each contraceptive method 
according to sociodemographic characteristics. We used 
Table 1: Contraceptive methods available in Canada, 
2009–2014, by effectiveness
Effectiveness;* method
Cost 
estimate†
Tier 1: < 1 pregnancy per 100 per year $$$
Intrauterine contraceptives (hormonal or 
nonhormonal), effective for up to 5 yr
Tier 2: 4–12 pregnancies per 100 per year $$
Injectable contraceptives (depot 
medroxyprogesterone acetate), repeated every 
3 mo
Oral contraceptives, vaginal ring or transdermal 
patch, repeated monthly
$$
Tier 3:  ≥ 18 pregnancies per 100 per year
Male condom $
Diaphragm + spermicide $$
Female condom $$
Fertility awareness methods/calendar Free–$
Withdrawal Free
No method Free
*Range of effectiveness represents typical use.3,12
†Cost varies because of differences in pharmacy/store discounts, pharmacists’ 
dispensing fees and supplemental insurance benefits. $ = least expensive, $$ = 
more expensive, $$$ = most expensive.
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survey weights provided with the CCHS public use data20,21 to 
account for the complex survey design. These enable accurate 
weighted point estimates but conservative variance estimates 
compared to cluster and primary sampling units or bootstrap 
weights. We assessed bivariate associations between each 
covariate and contraceptive method using a modified F  test 
(with Thomas–Rao modification),23 a version of a χ2 test for 
complex survey data with weights.
We used log binomial regression to estimate risk ratios 
(RRs) assessing the association between household income 
and the prevalence of each contraceptive method. For each 
contraceptive type, we estimated crude and adjusted RRs. 
The latter adjusted for all potential confounders identified 
on a priori grounds by means of causal diagrams: age, self-
identified race/ethnicity, highest level of education in the 
household, northern resident (Yukon Territory, Northwest 
Territories or Nunavut), student, married and recent immi-
grant.1,2,8,9,11,13,15,19,24 We conducted analyses using SAS  9.4 
(SAS Institute) and R-3.5.1 (R Foundation for Statistical 
Computing). All analyses applied sampling weights to 
achieve nationally representative estimates.20 Because we 
pooled 2  CCHS survey cycles, we divided weights by 2 to 
obtain a representative weighted population across both sur-
vey cycles.
Sensitivity analysis
We explored whether our results were robust to different 
definitions of household income by fitting additional mod-
els, first with the original 5-level household income variable 
obtained from the CCHS, and then adjusted for household 
size. To examine whether results may differ in Quebec 
owing to publicly funded drug benefits,1 we estimated RRs 
separately for Quebec and compared to all other provinces/
territories excluding Quebec. We identified potential vari-
ability in estimates (per CCHS cycle) by stratifying analyses 
for each survey cycle. Finally, we examined the potential 
impact of missing data in the covariates using multiple impu-
tation with chained equations25 to impute missing covariates 
for 20  data sets using the R package “mice.”26 We consid-
ered all possible covariates (with an absolute correlation with 
the response/imputed variable > 0.1) as predictors for impu-
tation. We repeated survey-weighted logistic regression 
models among imputed data sets to obtain pooled effect 
estimates.
Ethics approval
Ethics approval for using publicly available CCHS data is cov-
ered by University of British Columbia policies27 and the Tri-
Council Policy Statement.28
Results
Of all female survey respondents aged 15–24 (n = 15 290, rep-
resenting a national population of 2 137 242), 62.4% reported 
being sexually active. Our study sample included respondents 
at risk for unintended pregnancy; this included 48.1% of all 
female survey respondents (aged 15–24) and 81.0% of those 
2009–2010 CCHS
n = 124 188
2 cycles CCHS
n = 251 650 records
Respondents aged
15–24 yr
n = 30 857
Excluded: respondents 
aged < 15 yr and ≥ 25 yr
n = 220 793
Female respondents
n = 15 290
Excluded: males n = 15 567
Trying to avoid
pregnancy
n = 7535
Excluded: no/missing 
response to question “Have 
you ever had sexual
intercourse?” n = 5927
Ever had sexual
intercourse
n = 9363
Excluded: neutral/disagreed 
with statement “It is 
important to me to avoid 
getting pregnant right now”  
n = 1828
2013–2014 CCHS
n = 127 462
Excluded: missing covariates   
n = 420*
• Household education  n = 322
• Race/ethnicity  n = 54
• Immigration  n = 31
• Marital status  n = 16
Valid data for birth
control and household
income
n = 6445
Excluded  n = 1090
• Missing birth control response  
n = 25
• Missing household income  
n = 1065
Sample for analysis
n = 6025
Representing a weighted 
population of 826 711
Figure 1: Flow diagram showing selection of sample for analysis. Note: 
CCHS = Canadian Community Health Survey. *Numbers total more 
than 420 because some records were missing more than 1 value.
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who were sexually active (n = 6025 respondents, representing 
a national population of 826 711). Sexual activity differed by 
age group: 82.0% of respondents aged 20–24 had ever been 
sexually active, compared to 26.4% (15–17  yr) and 62.6% 
(18–19 yr) of younger respondents. Contraceptive nonuse was 
reported by 13.6% of the study sample. Rates of nonuse were 
lowest in Quebec (9.2%) and highest in the territories 
(19.4%). Oral contraceptives were the most popular method 
(59.2%), followed by condoms (47.6%), other methods 
(7.7%) and injectable DMPA (2.5%) (Table 2). Over one-
third of the study sample (36.5%) used more than 1 method, 
typically condoms with oral or injectable contraceptives 
(29.0%).
Table 3 shows the number of survey respondents in the 
study sample, corresponding population estimates (weighted 
frequencies) and weighted prevalence estimates for each con-
traceptive method, according to sociodemographic character-
istics. The lower-income group reported less use of oral con-
traceptives than the higher-income group (53.3% v. 69.0%), 
whereas the inverse was seen for use of DMPA (3.0% 
v.  1.5%) and condoms only (18.9% v. 13.3%). Although 
DMPA use was low overall, it was slightly higher in the 
2 lowest educational attainment groups (4.6% and 5.0%) than 
in the 2  highest educational attainment groups (2.3% and 
2.0%). Use of oral contraceptives was more prevalent among 
white females (63.2%) than among those who identified as a 
visible minority (43.3%), but there was no difference by mari-
tal status. Patterns of contraceptive use were different in the 
northern territories compared to the rest of Canada: com-
pared to nonnorthern residents, northern residents reported 
lower use of oral contraceptives and higher condom-only and 
DMPA use.
Table 4 presents unadjusted and adjusted RRs for all out-
comes, comparing prevalent method-specific use for lower 
versus higher household income categories. In adjusted mod-
els, compared to the higher household income group, lower 
household income was associated with decreased use of oral 
contraceptives (RR 0.85, 95% CI 0.80–0.91) and dual meth-
ods (RR 0.81, 95% CI 0.71–0.91, and increased use of DMPA 
(RR 1.7, 95% CI 0.98–2.9) and condoms only (RR 1.4, 95% 
CI 1.1–1.7). Adjustment for confounding variables attenuated 
associations for all outcomes. In models for oral contracep-
tives and DMPA, adjusting for household education level had 
the strongest impact on associations. In contrast, estimates for 
condom-only use were attenuated after adjustment for marital 
status, ethnicity and immigrant status.
Sensitivity analyses
We estimated the association of lower versus higher house-
hold income on contraceptive outcomes with imputed data for 
missing covariates (Supplemental Table S1, Appendix 1, avail-
able at www.cmajopen.ca/content/7/4/E646/suppl/DC1), and 
the results were similar to those of our primary analyses for all 
outcomes (Table 4). Using an income variable adjusted for 
household size yielded effect estimates with a consistent trend 
across income categories for all outcomes (Supplemental 
Tables S2-1 and S2-2, Appendix 1). Stratifying by the 
province of Quebec also yielded similar results for all out-
comes (Supplemental Tables S3-1 and S3-2, Appendix 1), 
with the exception of lower prevalence of nonuse of contra-
ceptives. Estimates were similar after stratification by CCHS 
cycle.
Interpretation
Using a nationally representative survey sample, we found 
that lower household income was associated with lower use of 
effective contraception methods. Specifically, those with 
lower household income were 15% less likely to use oral con-
traceptives and 19% less likely to use dual methods (condoms 
plus oral contraceptives or DMPA) than those with higher 
household income, after we adjusted for potential confound-
ers. Conversely, they were 69% more likely to use DMPA and 
36% more likely to use condoms only compared to the 
higher-income group. These findings are important as there 
is a paucity of recent nationally representative data on contra-
ceptive patterns, as well as limited information about how 
household income may be related to choice of contraceptive 
methods among youth at risk for unintended pregnancy in 
Canada.2 Similar to findings from previous Canadian studies, 
oral contraceptives and condoms were the predominant 
methods of contraception,1,13,19 and the highest prevalence of 
oral contraceptive use was among the youngest age group 
Table 2: Reported usual contraception method(s)
Method
Weighted 
population
n = 826 711*
Population-
weighted 
prevalence 
estimate, %† 
(95% CI)
Survey responses‡
Oral contraceptives§ 489 256 59.2 (57.2–61.2)
Condoms 393 446 47.6 (45.6–49.6)
Other 63 765 7.7 (6.6–8.8)
Injectable contraceptives 
(DMPA)¶
20 345 2.5 (1.9–3.0)
Diaphragm 8609 1.0 (0.7–1.4)
None 112 510 13.6 (12.3–15.0)
Derived results
Condoms and/or spermicide 
(no other methods 
indicated)¶
139 044 16.8 (15.3–18.4)
≥ 2 contraceptive methods 260 803 36.5 (34.5–38.6)
Condoms plus oral 
contraceptives or DMPA¶
240 022 29.0 (27.3–30.8)
Note: CI = confidence interval, DMPA = depot medroxyprogesterone acetate.
*Survey sample = 6025 respondents.
†Survey weighted.
‡Respondents could indicate more than 1 method to the question “What is your 
usual method of birth control?” Results for spermicide only not shown owing to 
low numbers.
§Primary outcome.
¶Secondary outcomes: injectable contraceptives and condom/spermicide.
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Table 3: Number of survey respondents, corresponding population estimates and weighted prevalence estimates for each 
contraceptive method, by sociodemographic characteristics
Covariate
Survey 
sample
 n = 6025
Weighted 
population,
no. (%)
n = 826 711
Contraceptive method; weighted prevalence estimate, % (95% CI)
Oral 
contraceptives
Injectable 
contraceptives Condom only* None
Annual household income, $
    < 80 000 3689 516 241 (62.4) 53.3 (50.7–55.9) 3.0 (2.2–3.8) 18.9 (16.9–21.0) 15.5 (13.7–17.3)
    ≥ 80 000 2336 310 470 (37.6) 69.0 (66.0–71.9) 1.5 (0.8–2.2) 13.3 (11.0–15.6) 10.5 (8.5–12.5)
Age, yr
    15–17 1045 95 467 (11.5) 63.7 (59.7–67.8) 2.4 (1.3–3.6) 15.2 (12.2–18.3) 16.3 (13.3–19.4)
    18–19 1325 157 515 (19.1) 59.2 (54.8–63.5) 2.6 (1.4–3.7) 17.8 (14.1–21.5) 14.9 (11.6–18.1)
    20–24 3655 573 729 (69.4) 58.4 (55.9–60.9) 2.4 (1.7–3.1) 16.8 (14.9–18.7) 12.8 (11.2–14.5)
Race/ethnicity
    White 4910 660 166 (79.9) 63.2 (61.0–65.3) 2.3 (1.7–2.9) 14.9 (13.2–16.6) 11.3 (10.0–12.7)
    Visible minority 1115 166 545 (20.1) 43.3 (38.5–48.1) 3.2 (1.8–4.6) 24.3 (20.5–28.2) 22.6 (18.7–26.5)
Current student
    No 2618 369 334 (44.7) 52.5 (49.4–55.7) 2.8 (1.9–3.7) 18.1 (15.5–20.6) 17.1 (14.8–19.5)
    Yes 3407 457 377 (55.3) 64.5 (62.1–67.0) 2.2 (1.5–2.9) 15.8 (13.9–17.7) 10.8 (9.2–12.3)
Married/common-law
    No 5063 676 199 (81.8) 59.9 (57.8–62.1) 2.4 (1.8–3.0) 17.7 (15.9–19.5) 13.2 (11.8–14.7)
    Yes 962 150 513 (18.2) 55.9 (50.9–60.9) 2.8 (1.4–4.2) 13.0 (10.0–15.9) 15.3 (11.7–19.0)
Recent immigrant†
    No 5871 787 812 (95.3) 60.2 (58.2–62.2) 2.5 (1.9–3.0) 15.8 (14.3–17.4) 13.5 (12.1–14.9)
    Yes 154 38 899 (4.7) 37.9 (27.3–48.5) < 2.0 37.0 (27.4–46.7) 16.5 (10.1–22.9)
Highest household education
    Less than high school 284 29 935 (3.6) 32.9 (23.8–42.1) 4.6 (1.8–7.5) 16.6 (4.8–28.4) 27.5 (19.4–35.7)
    Completed high school 730 89 807 (10.9) 46.0 (40.1–51.9) 5.0 (2.6–7.4) 20.7 (15.7–25.7) 19.6 (15.4–23.8)
    Some postsecondary 502 70 826 (8.6) 55.0 (47.7–62.3) 2.3 (0.3–4.3) 16.4 (11.5–21.3) 17.3 (11.9–22.6)
    Completed postsecondary 4509 636 143 (76.9) 62.7 (60.5–65.0) 2.0 (1.4–2.6) 16.3 (14.6–18.1) 11.7 (10.2–13.2)
Living arrangement
Unattached alone/single/
other
901 160 085 (21.3) 56.9 (51.8–62.0) 3.6 (2.0–5.1) 19.9 (15.8–24.0) 11.0 (8.3–13.8)
    With partner or spouse 525 92 736 (12.3) 67.0 (61.1–72.9) 2.3 (0.4–4.2) 10.9 (7.3–14.5) 11.0 (6.8–15.1)
    With partner and child 295 35 205 (4.7) 33.1 (23.8–42.4) 3.9 (1.0–6.8) 16.8 (10.1–23.4) 23.2 (15.4–31.1)
With own child/ren 
(no spouse)
219 20 809 (2.8) 33.7 (24.0–43.5) 4.1 (1.4–6.8) 12.6 (6.4–18.7) 28.2 (17.9–38.5)
Child living with parent(s) or 
siblings or both
3579 444 087 (59.0) 63.3 (60.8–65.8) 1.7 (1.1–2.3) 17.0 (14.9–19.1) 12.7 (11.0–14.4)
Consulted doctor or nurse in 
previous 12 mo
    No 744 104 844 (12.7) 42.4 (36.3–48.5) 1.5 (0.4–2.6) 26.8 (21.9–31.8) 22.9 (17.9–27.8)
    Yes 5278 721 490 (87.3) 61.6 (59.5–63.7) 2.6 (2.0–3.2) 15.4 (13.7–17.0) 12.3 (10.9–13.6)
Has family doctor
    No 1132 168 906 (20.5) 48.1 (43.2–53.0) 2.0 (0.8–3.3) 21.0 (17.2–24.8) 18.2 (14.5–21.9)
    Yes 4887 656 656 (79.5) 62.0 (59.9–64.2) 2.6 (2.0–3.2) 15.7 (14.0–17.4) 12.5 (11.0–13.9)
Northern resident‡
    No 5823 823 779 (99.6) 59.3 (57.3–61.3) 2.4 (1.9–3.0) 16.8 (15.2–18.4) 13.6 (12.2–14.9)
    Yes 202 2933 (0.4) 33.9 (26.3–41.6) 9.6 (4.2–15.0) 22.5 (15.4–29.7) 19.4 (12.7–26.1)
Quebec resident§
    No 4747 619 576 (74.9) 57.9 (55.6–60.2) 2.6 (2.0–3.3) 17.2 (15.4–19.0) 15.1 (13.5–16.7)
    Yes 1278 207 135 (25.1) 63.1 (59.1–67.1) 1.9 (0.9–2.9) 15.8 (12.8–18.7) 9.2 (6.8–11.6)
Note: CI = confidence interval.
*Includes those who used only spermicide and/or condoms.
†Immigrated to Canada within the previous 10 years.
‡Resident of the Yukon Territory, Northwest Territories or Nunavut.
§Quebec has a publicly funded prescription benefit program that includes contraceptive coverage for youth who are not already covered by a private drug plan.
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(15–17 yr).1,19,29 We also note that the association with income 
differed for oral contraceptives compared to DMPA or con-
doms in unadjusted analyses and after we controlled for con-
founding. This trend was consistent in models using a 5-level 
income variable adjusted for household size.
Although previous Canadian studies identified greater oral 
contraceptive use by higher income status,19,29 these analyses 
did not focus on income as the exposure of interest. Our find-
ings suggest that young females from higher-income house-
holds may be able to access a broader range of effective con-
traceptive methods, perhaps because cost is reduced or 
eliminated as a barrier.15 Higher-income families may also 
have prescription drug benefits to subsidize costs of contra-
ceptives.30 Furthermore, young females from higher-income 
households were also more likely to use multiple contracep-
tive methods, which provides greater protection against unin-
tended pregnancies than oral contraceptives alone while also 
reducing the risk of sexually transmitted infections.
Although DMPA use is relatively low in Canada, we found 
increased use of DMPA among low-income female youth 
across Canada, with even higher use in the territories. This 
could be due to unexamined confounders, such as differences 
in provider counselling, contraceptive access, health insur-
ance or patient preferences. In the United States, DMPA use 
is higher among certain vulnerable populations, including 
Indigenous,31 racial or ethnic minorities32 and those with low 
income.33,34 Although DMPA provides effective contracep-
tion and is preferred by some, it has a controversial history, 
including targeted marketing and provision to vulnerable 
groups, which may indicate reproductive coercion.35–38 Fur-
thermore, the side effects of bone density loss and weight 
gain39,40 may be particularly important for youth. Our find-
ings warrant further examination by means of both qualita-
tive and quantitative methods to elucidate reasons for the dif-
ferential patterns of use in low-income and northern 
Canadian populations. Choices about contraceptive use are 
multifactorial and are affected by a variety of factors, includ-
ing personal experiences, provider counselling and practice 
patterns, and access to care.
Our findings signal a need for further research aimed at 
identifying and eliminating barriers to accessing safe, effective 
contraception in Canada.41 Policies and educational initiatives 
relating to family planning and prevention of sexually trans-
mitted disease should consider the unique reproductive needs 
of young females, especially those within vulnerable popula-
tions, who are at greatest risk for unintended pregnancy.
Limitations
Our results are based on self-reported survey data and may be 
misclassified, which would underestimate our measures of 
association. We could not include the 2011–2012 CCHS 
cycle in this study as contraception questions were asked in 
only 1 province (Ontario) and 2 territories (Northwest Terri-
tories and Nunavut), which would limit the generalizability of 
our results. Furthermore, these CCHS cycles did not include 
questions about intrauterine contraceptives, which prevented 
us from extending our analyses to these long-acting, highly 
effective contraceptive methods. Although newer CCHS 
cycles (from 2015) do ask about intrauterine contraceptives, 
questions relating to pregnancy intention have been elimi-
nated. Thus, the newer CCHS surveys cannot directly iden-
tify people who need contraception: those at risk for unin-
tended pregnancy. As this group forms the denominator to 
assess contraception use, it is no longer possible in Canada to 
use the CCHS to determine the unmet need for contracep-
tion or the rates of methods for those who need contracep-
tion, nor is there any other nationally representative data 
source to determine this important information. Because the 
CCHS asks only those aged 18 years or more about sexual 
orientation, our sample may include a small number of homo-
sexual females not at risk for unintended pregnancy; however, 
Pakula42 reported that less than 2% of all 2007–2012 CCHS 
respondents identified as homosexual. We used household 
education to represent family socioeconomic status; however, 
because some respondents were not living with any members 
of their family, this covariate may be inconsistent as a measure 
of socioeconomic status. We used household income as a 
proxy for ability to pay for contraceptives, which may not 
Table 4: Association of lower versus higher annual household income on contraceptive methods
Primary outcome
Household income; weighted 
frequencies Crude RR 
(95% CI) for 
lower-income 
group
Adjusted RR* 
(95% CI) for 
lower-income 
group
< $80 000
n = 516 241
≥ $80 000
n = 310 470
Oral contraceptives 275 176 214 080 0.77 (0.72–0.83) 0.85 (0.80–0.91)
Injectable contraceptives (DMPA) 15 573 4772 1.96 (1.16–3.32) 1.69 (0.98–2.92)
Condom only 97 682 41 363 1.42 (1.16–1.74) 1.36 (1.11–1.67)
Nonusers (no contraceptive method) 79 856 32 654 1.47 (1.17–1.84) 1.19 (0.94–1.50)
Multiple methods: condoms plus oral 
contraceptives or DMPA
126 256 113 766 0.67 (0.59–0.75) 0.81 (0.71–0.91)
Note: CI = confidence interval, DMPA = depot medroxyprogesterone acetate, RR = relative risk.
*Adjusted for household income, age, race/ethnicity, immigrant status, student status, marital status, household level of education and northern residence.
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perfectly equate to individual financial status or may be a 
marker for other unmeasured confounders. Although we con-
trolled for all measured confounders in our adjusted analyses, 
there may be residual confounding by variables not captured 
in the CCHS data sets, such as religion, cultural norms, prior 
adverse events or the use of contraceptives for noncontracep-
tive purpose (e.g.,  treatment of irregular menstrual periods, 
acne, hirsutism). Finally, by nature of the CCHS’s cross-
sectional design, associations between income and contracep-
tive use cannot be interpreted causally.
Conclusion
In a nationally representative sample of young Canadian 
females at risk for unintended pregnancy, we found that 
lower household income was associated with decreased use 
of oral contraceptives and increased reliance on injectable 
contraceptives and condoms only. Our results are consistent 
with other recent findings that show substantial variations in 
contraceptive use within Canada, with lower use of more 
effective contraceptive methods among vulnerable groups. 
Collectively, these findings suggest that subsidizing or elim-
inating costs for contraceptives, as called for in a recent 
position statement by the Canadian Paediatric Society,43 
could promote equitable access to more effective methods of 
birth control among low-income youth at risk for unin-
tended pregnancy.
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